Drs. George Vetrovec, Mirvat Alasnag, and Peter Block discuss key takeaways for interventionalists from late-breaking clinical trials presented at TCT 2020, including PROSPECT ABSORB (2:05), Disrupt CAD III (5:20), REFLECT II and STS/ACC TVT Registry (8:14), and Bivalirudin vs Heparin in MI Patients (13:10).